Evaluating culture-free targeted next-generation sequencing for diagnosing drug-resistant tuberculosis: a multicentre clinical study of two end-to-end commercial workflows.
- DOI
- 10.1016/s1473-3099(24)00586-3
- Published
- 2025 Mar
- Container
- The Lancet. Infectious diseases
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s1473-3099-24-00586-3,
title = {Evaluating culture-free targeted next-generation sequencing for diagnosing drug-resistant tuberculosis: a multicentre clinical study of two end-to-end commercial workflows.},
author = {Colman RE and Seifert M and De la Rossa A and Georghiou SB and Hoogland C and Uplekar S and Laurent S and Rodrigues C and Kambli P and Tukvadze N and Maghradze N and Omar SV and Joseph L and Suresh A and Rodwell TC},
year = {2025},
journal = {The Lancet. Infectious diseases},
doi = {10.1016/s1473-3099(24)00586-3},
url = {https://doi.org/10.1016/s1473-3099(24)00586-3}
}RIS
TY - JOUR TI - Evaluating culture-free targeted next-generation sequencing for diagnosing drug-resistant tuberculosis: a multicentre clinical study of two end-to-end commercial workflows. AU - Colman RE AU - Seifert M AU - De la Rossa A AU - Georghiou SB AU - Hoogland C AU - Uplekar S AU - Laurent S AU - Rodrigues C AU - Kambli P AU - Tukvadze N AU - Maghradze N AU - Omar SV AU - Joseph L AU - Suresh A AU - Rodwell TC PY - 2025 JO - The Lancet. Infectious diseases DO - 10.1016/s1473-3099(24)00586-3 UR - https://doi.org/10.1016/s1473-3099(24)00586-3 ER -
APA
RE, C., M, S., A, D. L. R., SB, G., C, H., S, U., S, L., C, R., P, K., N, T., N, M., SV, O., L, J., A, S., & TC, R. (2025). Evaluating culture-free targeted next-generation sequencing for diagnosing drug-resistant tuberculosis: a multicentre clinical study of two end-to-end commercial workflows.. The Lancet. Infectious diseases. https://doi.org/10.1016/s1473-3099(24)00586-3
Source records
- pubmed · retrieved 2026-09-26T06:50:51.778Z